Skip to content

Monitoring Patterns of Prescribing to Identify Changes in Access to ER/LA Opioid Analgesics

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02920775
Enrollment
360000
Registered
2016-09-30
Start date
Unknown
Completion date
Unknown
Last updated
2016-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug Abuse, Narcotic Abuse, Opiate Addiction, Opioid Related Disorders

Brief summary

Changes in prescribing will be compared in prescribers from specialties whose prescribing is hypothesized to be relatively unaffected by the REMS (such as oncologists and hospice providers) versus those for whom the REMS could have greater impact on prescribing (e.g., dentists). Trends and changes in monthly prescription volume and average monthly prescription volume will be evaluated by prescriber specialty.

Interventions

Sponsors

ER/LA Opioid REMS Program Companies (RPC)
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 100 Years

Inclusion criteria

* Changes in number of prescriptions for prescriber types with less or more compelling reasons to prescriber ER/LA opioid analgesics

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frame
Monthly volume of prescriptions by specialtyJuly 2010-December 2014

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026